Antiplatelet agents and anticoagulants are a mainstay for the prevention and treatment of
thrombosis. However, despite advances in antithrombotic therapy, a fundamental challenge …

Although many patients do not receive reperfusion therapy because of delayed presentation
and/or severity and location of infarct, new reperfusion approaches are expanding the …

Adaptive designs for clinical trials permit alterations to a study in response to accumulating
data in order to make trials more flexible, ethical, and efficient. These benefits are achieved …

Soluble thrombomodulin plasma concentrations are elevated in steroid-resistant graft-
versus-host disease (GVHD), implying endothelial hypofunctioning for thrombomodulin …